The evolution of lymph node assessment in breast cancer

Journal of Surgical Oncology

Volumn 99, Issue 4, 2009, Pages 194-198

  Quan, May Lynn ^a   McCready, David ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Axillary dissection; Breast cancer; Lymph node; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT;

AXILLARY LYMPH NODE; BREAST CANCER; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE ASSOCIATION; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; QUALITY ASSURANCE, HEALTH CARE; SENTINEL LYMPH NODE BIOPSY;

EID: 62749172432     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21201     Document Type: Review

References (62)

1. Halsted WSI: The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907;46:1-19.
2. Urban JA: Extended radical mastectomy for breast cancer. Am J Surg 1963;106:399-404.
3. Veronesi U, Marubini E, Mariani L, et al.: The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 1999;35:1320-1325.
4. Fisher B: Laboratory and clinical research in breast cancer - a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res 1980;40:3863-3874.
5. Fisher B, Jeong JH, Anderson S, et al.: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002;347:567-575.
6. Punglia RS, Morrow M, Winer EP, et al.: Local therapy and survival in breast cancer. N Engl J Med 2007;356:2399-2405.
7. Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Oncol 1999;6:1:109-116.
8. Louis-Sylvestre C, Clough K, Asselain B, et al.: Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 2004;22:1:97-101.
9. Overgaard M, Hansen PS, Overgaard J, et al.: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-955.
10. Ragaz J, Jackson SM, Le N, et al.: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-962.
11. Ragaz J, Olivotto IA, Spinelli JJ, et al.: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116-126.
12. Clarke M, Collins R, Darby S, et al.: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-2106.
13. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-1717.
14. Cady B: A contemporary view of axillary dissection. Ann Surg 2000;232:8-9.
15. Greco M, Agresti R, Cascinelli N, et al.: Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg 2000;232:1-7.
16. Anonymous Axillary dissection: The steering committee on clinical practice guidelines for the care and treatment of breast cancer. Canadian Association of Radiation Oncologists. CMAJ 1998;158:S22-S26.
17. Riveros M, Garcia R, Cabanas R: Lymphadenography of the dorsal lymphatics of the penis. Technique and results. Cancer 1967;20:2026-2031.
18. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
19. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
20. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398; discussion 398-401.
21. Krag D, Weaver D, Ashikaga T, et al.: The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-946.
22. Fleissig A, Fallowfield LJ, Langridge CI, et al.: Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006;95:279-293.
23. Veronesi U, Paganelli G, Viale G, et al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-553.
24. Mansel RE, Fallowfield L, Kissin M, et al.: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609.
25. McMasters KM, Tuttle TM, Carlson DJ, et al.: Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-2566.
26. Martin RC 2nd, Edwards MJ, Wong SL, et al.: Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group. Surgery 2000;128:139-144.
27. Lyman GH, Giuliano AE, Somerfield MR, et al.: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720.
28. Swenson KK, Nissen MJ, Ceronsky C, et al.: Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002;9:745-753.
29. Veronesi U, Paganelli G, Viale G, et al.: Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983-990.
30. American Society of Breast Surgeons: Consensus Statement on Guidelines for Performing Sentinel Lymph Node Dissection in Breast Cancer. 2006.
31. Cantin J, Scarth H, Levine M, et al.: Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. CMAJ 2001;165:166-173.
32. Chen SL, Iddings DM, Scheri RP, et al.: Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin 2006;56:292-309; quiz 316-317.
33. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer V2.2007 [Online]. http://www.nccn.org/professionals/ physician-gls/PDF/breast.pdf [10/24/2007].
34. Lucci A, Jr, Kelemen PR, Miller C 3rd, et al.: National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 2001;192:453-458.
35. Porter GA, McMulkin H, Lovrics PJ: Sentinel lymph node biopsy in breast cancer: Canadian practice patterns. Ann Surg Oncol 2003;10:255-260.
36. Quan ML, Hodgson N, Porter GA, et al.: National integration of sentinel node biopsy for breast cancer: Lessons learned from the Canadian experience. Breast 2008;14:421-427.
37. Krag DN, Julian TB, Harlow SP, et al.: NSABP-32: phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial. Ann Surg Oncol 2004;11:208S-210S.
38. White RL, Jr, Wilke LG: Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 2004;70:420-424.
39. Krag DN, Anderson SJ, Julian TB, et al.: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymphnode dissection in patients with clinically node-negative breast cancer: results from the NSAP B-32 randomised phase III trial. Lancet Oncol 2007;8:881-888.
40. Fitzgibbons PL, Page DL, Weaver D, et al.: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-978.
41. Dowlatshahi K, Fan M, Snider HC, et al.: Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-1197.
42. Cote RJ, Peterson HF, Chaiwun B, et al.: Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999;354:896-900.
43. Pargaonkar AS, Beissner RS, Snyder S, et al.: Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med 2003;127:701-705.
44. Association of Directors of Anatomic and Surgical Pathology: ADASP recommendations for processing and reporting lymph node specimens submitted for evaluation of metastatic disease. Am J Surg Pathol 2001;25:961-963.
45. Greene FL, Page DL, Fleming ID: AJCC cancer staging manual. New York: Springer; 2002.
46. Singletary SE, Allred C, Ashley P, et al.: Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 2003;83:803-819.
47. Chen SL, Hoehne FM, Giuliano AE: The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 2007;14:3378-3384.
48. Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006;106:4-16.
49. McCready DR, Yong WS, Ng AK, et al.: Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. J Natl Cancer Inst 2004;96:873-875.
50. Tan LK, Giri D, Hummer AJ, et al.: Occult axillary node metastases in breast cancer are prognostically significant: Results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 2008;26:1803-1809.
51. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al.: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003;10:1140-1151.
52. Smidt ML, Kuster DM, van der Wilt GJ, et al.: Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 2005;12:1066-1072.
53. Van Zee KJ, Kattan MW: Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer. Ann Surg Oncol 2007;14:2177-2178.
54. Ramjasingh R, Quan ML, Gardner S, et al.: Validation of the MSKCC nomogram in a cohort of Canadian women with breast cancer. CJS in press 2008.
55. McMasters KM: The eternally enigmatic axilla: further controversy about axillary lymph nodes in breast cancer. Ann Surg Oncol 2003;10:1128-1130.
56. Clarke D, Newcombe RG, Mansel RE: ALMANAC Trialists Group. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 2004;11:211S-215S.
57. Harlow SP, Krag DN, Julian TB, et al.: Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005;241:48-54.
58. Posther KE, McCall LM, Blumencranz PW, et al.: Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg 2005;242:593-599; discussion 599-602.
59. Lohr KN, Donaldson MS, Harris-Wehling J: Medicare: a strategy for quality assurance, V: quality of care in a changing health care environment. QRB Qual Rev Bull 1992;18:120-126.
60. Malin JL, Asch SM, Kerr EA, et al.: Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool. Cancer 2000;88:701-707.
61. Cancer Care Ontario: Breast Cancer Surgery Quality Indicators [Online]. http://www.cancercare.on.ca/pdf/breast-indicators-ccoweb-.pdf [02/29 2008].
62. Schachter HM, Mamaladze V, Lewin G, et al.: Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: A systematic review. BMC Cancer 2006;6:291.